Home/Formosa Pharmaceuticals/Dr. Chen-Yu Cheng
DC

Dr. Chen-Yu Cheng

Chairman and Founder

Formosa Pharmaceuticals

Formosa Pharmaceuticals Pipeline

DrugIndicationPhase
APP13007Inflammation and pain after ocular surgeryApproved
APP13002Bacterial conjunctivitis, keratitis, blepharitis, Meibomian Gland DysfunctionPreclinical/Clinical
TSY-110HER2-positive cancers (ADC biosimilar)Development
TSY-120HER2-positive cancers (ADC biosimilar)Development
TSY-310Solid tumors (bispecific ADC)Development